Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF AND MEDICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/198138
Kind Code:
A1
Abstract:
Provided are an anti-ERBB3 antibody or an antigen-binding fragment thereof, and the medical use thereof. Provided are an anti-ERBB3 receptor fully human antibody or an antigen-binding fragment thereof, and the medical use thereof. Provided are a pharmaceutical composition comprising the anti-ERBB3 fully human antibody or the antigen-binding fragment thereof, and the use of the pharmaceutical composition as an anti-cancer drug.

Inventors:
MAO DONGJIE (CN)
XIE YUEJUN (CN)
Application Number:
PCT/CN2023/087967
Publication Date:
October 19, 2023
Filing Date:
April 13, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI HANSOH BIOMEDICAL CO LTD (CN)
CHANGZHOU HANSOH PHARMACEUTICAL CO LTD (CN)
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
C07K16/32; A61K39/395; A61P35/00; C12N15/00; G01N33/574; G01N33/68
Domestic Patent References:
WO2022078490A12022-04-21
Foreign References:
CN103002912A2013-03-27
CN105120890A2015-12-02
CN115843256A2023-03-24
US20090291085A12009-11-26
US20130224220A12013-08-29
US20200339702A12020-10-29
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF: